Quadrature Capital’s MDxHealth MDXH Stock Holding History

Quadrature Capital’s Portfolio MDXH Stock Details MDXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,749	Closed	-$77.7K	–	1510
2025 Q3	$77.7K	Buy	+16,749	New	+$51.5K	﹤0.01%	909

Other funds holding MDXH

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

Samjo Management New York $231M AUM 13.04% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

FreeGulliver LLC New Orleans, Louisiana $237M AUM 21.92% 1-Year Est. Return

Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Quadrature Capital's MDXH Position: Q4 2025 in Review

Quadrature Capital sold out of MDxHealth (MDXH) in Q4 2025, closing a stake of 16,749 shares — an estimated $77.7K sold.

Quadrature Capital first reported a position in MDXH in Q3 2025 and held it in 1 quarter. The position peaked at $77.7K in Q3 2025. 56 funds tracked by Wall St. Rank hold MDXH as of Q4 2025.

Quadrature Capital reported no remaining MDxHealth position as of Q4 2025 after selling out during the quarter.
Quadrature Capital sold 16,749 MDxHealth shares in Q4 2025, an estimated $77.7K.
Quadrature Capital first reported a position in MDxHealth in Q3 2025 and held it in 1 quarter.
Quadrature Capital's MDxHealth position peaked at $77.7K in Q3 2025.
56 funds tracked by Wall St. Rank held MDxHealth as of Q4 2025.

Based on Quadrature Capital's 13F filing for Q4 2025, filed 17 Feb 2026.